Litcius/Paper detail

SO-9 Outcomes for patients with advanced hepatocellular carcinoma and Child-Pugh B liver function in the phase 3 CELESTIAL study of cabozantinib vs placebo

Anthony B. El-Khoueiry, Tim Meyer, Ann‐Lii Cheng, Lorenza Rimassa, Seema Sen, Steven Milwee, Robin Kate Kelley, G.K. Abou-Alfa

2020Annals of Oncology14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCabozantinibHepatocellular carcinomaPlaceboInternal medicineCirrhosisRandomizationSorafenibGastroenterologyLiver functionSubgroup analysisClinical trialOncologyCancerPathologyConfidence intervalAlternative medicineHepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and StudiesLiver Disease Diagnosis and Treatment
SO-9 Outcomes for patients with advanced hepatocellular carcinoma and Child-Pugh B liver function in the phase 3 CELESTIAL study of cabozantinib vs placebo | Litcius